The company website has just posted a very interesting blog post by Dr Graham Kelly on the subject of IPO launch share prices in the biotech and pharmaceutical area.
https://www.noxopharm.com/site/Blog/a-comment-on-ipo-returns?_=1539734569489
Well worth a read to put things into some perspective. Particularly interesting at the moment when compared to some of the posts and opinions being voiced over on the KAZ board regarding the current trading halt.
Apples